8-K current report · filed Sep 30, 2026

Grindr Inc. (GRND) 8-K Current Report: September 30, 2026

Item EX-99.1Item EX-99.2Item 1.01Item 3.02Item 7.01GRND overview

Short answer

Grindr Inc. (GRND) filed an 8-K current report with the SEC on September 30, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2), Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure). PurposeMed acquisition for $250M base consideration: $190M cash plus 3,851,684 Grindr shares valued at $15.58 each.

Grindr Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • PurposeMed acquisition for $250M base consideration: $190M cash plus 3,851,684 Grindr shares valued at $15.58 each
  • Additional earnout up to $70M cash, contingent on PurposeMed’s 2027 financial performance
  • Target owns Freddie, a PrEP and HIV-prevention telehealth brand, adding clinical-network partnerships to Grindr’s healthcare platform
  • Issued shares subject to a 12-month lock-up, creating future dilution but limiting immediate selling pressure
  • Closing requires NYSE share approval and other conditions, with termination available if not completed by December 30, 2026

Item 3.02 · Unregistered Sales of Equity Securities

  • GRND will issue Common Stock to transaction sellers, creating potential shareholder dilution
  • Issuance relies on Section 4(a)(2) private-placement exemption, avoiding registered public offering requirements
  • Seller investment representations support restricted, non-public issuance status
  • Share count, transaction value, and dilution magnitude require review of Item 1.01 and purchase agreement

Item 7.01 · Regulation FD Disclosure

  • September 30, 2026 press release announced entry into a Purchase Agreement
  • Shareholder letter provided additional transaction context for investors
  • Agreement terms and financial impact require review of Exhibits 99.1 and 99.2

Item EX-99.1 · Exhibit EX-99.1

  • First major acquisition: PurposeMed/Freddie for $250M, comprising $190M cash and $60M Grindr stock
  • Additional earn-out of up to $70M cash tied to 2027 targets, payable in 2028
  • Freddie expected to generate over $80M 2026 revenue and over $10M Adjusted EBITDA
  • Strategic expansion into telehealth and PrEP, reaching Freddie’s 55,000-plus patients and all 50 US states
  • Immaterial 2026 financial impact, with 2027 outlook details deferred to Grindr’s November earnings call

Item EX-99.2 · Exhibit EX-99.2

  • Acquisition of PurposeMed/Freddie for $250M: $190M cash and $60M Grindr stock
  • Additional earn-out up to $70M cash tied to 2027 targets, payable in 2028
  • Freddie expects 2026 revenue above $80M and Adjusted EBITDA above $10M
  • Strategic entry into telehealth PrEP: over 55,000 patients served across 50 states and Washington, DC
  • Closing expected in Q4 2026, with integration investment initially dilutive to margin percentage

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Grindr Inc. 8-K filings

Get the next GRND 8-K as it lands

Follow GRND for push alerts, or ask the research agent what this filing means.